Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangxinkang Tablets for chronic heart failure
ChiCTR-TRC-09000549Phase 3Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jan 2008
- Countries
- 1
01
Overview
Phase 3, randomised trial of Yangxinkang in chronic heart failure (CHF) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Heart function grade. Started Jan 2008; status: completed.
02
Drugs
Yangxinkang
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-TRC-09000549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000549.